Atlas Trials

Efficacy and Safety of Keverprazan-amoxicillin Dual Therapy for Helicobacter Pylori First-line Treatment

Clinical trial NCT07122024 · RECRUITING

Trial details

NCT number
NCT07122024
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Helicobacter Pylori
Start date
2024-02-19
Primary completion
2025-08-31
Enrollment
414

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.